John Overdeck’s Minerva Neurosciences NERV Stock Holding History

John Overdeck’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142K	Buy	25,675 +4,281	+20%	+$23.2K	﹤0.01%	4841
2026 Q1	$129K	Sell	21,394 -900	-4%	-$5.16K	﹤0.01%	4355
2025 Q4	$89.6K	Buy	+22,294	New	+$82.8K	﹤0.01%	3867
2021 Q3	–	Sell	-32,749	Closed	-$608K	–	4543
2021 Q2	$608K	Sell	32,749 -22,114	-40%	-$476K	﹤0.01%	2924
2021 Q1	$1.28M	Buy	54,863 +931	+2%	+$23.3K	﹤0.01%	2087
2020 Q4	$1.01M	Buy	53,932 +28,948	+116%	+$729K	﹤0.01%	2004
2020 Q3	$636K	Buy	+24,984	New	+$675K	﹤0.01%	2062
2020 Q1	–	Sell	-2,313	Closed	-$132K	–	3602
2019 Q4	$132K	Buy	+2,313	New	+$102K	﹤0.01%	3497
2019 Q1	–	Sell	-5,887	Closed	-$317K	–	3332
2018 Q4	$317K	Buy	5,887 +2,797	+91%	+$205K	﹤0.01%	2409
2018 Q3	$310K	Buy	+3,090	New	+$232K	﹤0.01%	2756

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

John Overdeck's NERV Position: Q2 2026 in Review

John Overdeck increased its Minerva Neurosciences (NERV) stake by 20% in Q2 2026, buying an estimated $23.2K and bringing the position to 25,675 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #4841.

John Overdeck first reported a position in NERV in Q3 2018 and has held it in 10 quarters since. The position peaked at $1.28M in Q1 2021. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

John Overdeck held 25,675 shares of Minerva Neurosciences worth $142K as of Q2 2026.
John Overdeck bought 4,281 Minerva Neurosciences shares in Q2 2026, an estimated $23.2K.
Minerva Neurosciences made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4841 holding.
John Overdeck first reported a position in Minerva Neurosciences in Q3 2018 and has held it in 10 quarters since.
John Overdeck's Minerva Neurosciences position peaked at $1.28M in Q1 2021.
60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.